Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

This bill prohibits health insurers, pharmacy benefits managers, and state health benefit programs from requiring pre-approval or precertification for cancer treatments, tests, procedures, or prescription drugs that are already covered under a patient's plan and prescribed by a licensed doctor. It directly affects cancer patients and their healthcare providers by removing bureaucratic delays caused by insurance approval processes. Key provisions ban these requirements for all covered cancer-related care under health benefits plans, including state programs like the State Health Benefits Program. The bill aims to ensure patients receive timely treatment without insurance-related administrative hurdles. (Note: Bill introduced January 9, 2024, referred to Senate Commerce Committee.)